Grant of Warrants
December 08, 2022 12:47 ET
|
BioPorto A/S
December 8, 2022Announcement no. 18 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, December 8, 2022, (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (BioPorto or Company)...
BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC
December 05, 2022 12:47 ET
|
BioPorto A/S
December 5, 2022News Release BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC COPENHAGEN, DENMARK and BOSTON, MA, December 5, 2022, (GLOBE NEWSWIRE)...
Resolutions of the Extraordinary General Meeting of BioPorto A/S
November 23, 2022 03:36 ET
|
BioPorto A/S
November 23, 2022 Announcement no. 17 Resolutions of the Extraordinary General Meeting of BioPorto A/S COPENHAGEN, DENMARK and BOSTON, MA, USA, November 23, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S...
Correction: BioPorto Submits Application for Marketing Authorization of NGAL Test to the US Food and Drug Administration
November 10, 2022 14:51 ET
|
BioPorto A/S
November 10, 2022 Announcement no. 16 BioPorto Submits Application for Marketing Authorization of NGAL Test to the US Food and Drug Administration COPENHAGEN, DENMARK and BOSTON, MA, USA,...
BioPorto Submits Application for Marketing Authorization of NGAL Test to the US Food and Drug Administration
November 10, 2022 14:27 ET
|
BioPorto A/S
November 10, 2022 Announcement no. 16 BioPorto Submits Application for Marketing Authorization of NGAL Test to the US Food and Drug Administration COPENHAGEN, DENMARK and BOSTON, MA, USA, November...
BioPorto Announces Interim Results for the First Nine Months of 2022
November 09, 2022 02:01 ET
|
BioPorto A/S
November 9, 2022 Announcement no. 15 BioPorto Announces Interim Results for the First Nine Months of 2022 COPENHAGEN, Denmark and BOSTON, MA, USA, November 9, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S...
BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call
November 03, 2022 12:00 ET
|
BioPorto A/S
November 3, 2022News release BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call COPENHAGEN, DENMARK and BOSTON, MA, USA, November 3, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto)...
NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING
November 01, 2022 10:00 ET
|
BioPorto A/S
November 1, 2022 Announcement no. 14 NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING In accordance with Article 5 of the Articles of Association, the Board of Directors hereby...
Update: BioPorto Exhibiting NGAL Biomarker at ASN Kidney Week – Antibodies, ELISA kits, and Clinical Chemistry Assays for Early Drug Development and Clinical Research
October 27, 2022 15:03 ET
|
BioPorto A/S
October 27, 2022 Press release BioPorto Exhibiting NGAL Biomarker at ASN Kidney Week – Antibodies, ELISA kits, and Clinical Chemistry Assays for Early Drug Development and Clinical...
BioPorto Exhibiting NGAL Biomarker at ASN Kidney Week – Antibodies, ELISA kits, and Clinical Chemistry Assays for Early Drug Development and Clinical Research
October 27, 2022 14:00 ET
|
BioPorto A/S
October 27, 2022 Press release BioPorto Exhibiting NGAL Biomarker at ASN Kidney Week – Antibodies, ELISA kits, and Clinical Chemistry Assays for Early Drug Development and Clinical Research...